- Medical - Instruments & Supplies
- Healthcare
-
4.85
EPS
-
7.60
P/E
-
18.8B
MARKET CAP
-
3.14%
DIV YIELD
Company Overview
ONE BAXTER PKWY,DEERFIELD IL 60015,8479482000
CEO
Mr. Jose E. Almeida
Employess
60000
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Website
https://www.baxter.com
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Next Earnings Date
Oct. 31, 2024
Ex Dividends date
Oct. 01, 2024
Dividend Date
Aug. 30, 2024
YTD Performance
-4.97%
Fiscal Year End
12-31
IPO Date
1981-10-27
Growth Rates
(avg. rate of change) | 10 years | 5 years | 3 years | 1 year |
---|---|---|---|---|
Sales/Revenue | -0.30% | 5.89% | 8.26% | -1.99% |
EPS | -1.15% | -2.80% | -6.48% | 90.63% |
Equity | -0.07% | 1.51% | -1.11% | 44.04% |
Cash | 1.58% | 11.79% | -5.00% | 86.15% |
Return On Capital (ROIC) | 5.27% | 2.38% | 0.41% | 1.17% |
Debt
year (millions) | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Short Term Debt | 2,800 | 1,520 | 639 | 517 | 642 |
Long Term Debt | 11,100 | 15,700 | 17,700 | 6,290 | 5,320 |
LT Finance Leases | 504 | 577 | 650 | 612 | 611 |
Shares Outstanding | 506 | 504 | 502 | 509 | 509 |
Market Cap | 19,600 | 25,700 | 43,100 | 40,800 | 42,600 |
Price
News
Baxter (BAX) Q2 Earnings Beat Estimates, '24 EPS View Raised
1 monthBaxter (BAX) reports better-than-expected second-quarter earnings and sales. Its quarterly results reflect solid demand for a range of its medically essential products.
zacks.comBaxter International Inc. (BAX) Q2 2024 Earnings Call Transcript
1 monthBaxter International Inc. (NYSE:BAX ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President, Chief Investor Relations Officer Joe Almeida - Chairman & Chief Executive Officer Joel Grade - Executive Vice President & Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Travis Steed - Bank of America Securities David Roman - Goldman Sachs Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Danielle Antalffy - UBS Matt Miksic - Barclays Rick Wise - Stifel Pito Chickering - Deutsche Bank Operator Good morning, ladies and gentlemen, and welcome to Baxter International's Second Quarter 2024 Earnings Conference Call. Your lines will remain in a listen-only mode until the question-and-answer segment of today's call.
seekingalpha.comCompared to Estimates, Baxter (BAX) Q2 Earnings: A Look at Key Metrics
1 monthThe headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zacks.comBaxter International (BAX) Beats Q2 Earnings and Revenue Estimates
1 monthBaxter International (BAX) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.55 per share a year ago.
zacks.comThe Zacks Analyst Blog Baxter International, Henry Schein and IDEXX Laboratories
1 monthBaxter International, Henry Schein and IDEXX Laboratories are included in this Analyst Blog.
zacks.comThe Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data
1 monthThis marks the last peak week of the Q2 earnings season with 3,908 companies expected to report. Earnings have come in better-than-expected, but tend to be overshadowed by economic data. Outlier earnings this week include: CSX, CAT, and VFC.
seekingalpha.com3 Contrarian Stock Picks to Buy Against the Market Consensus
1 monthHeightened volatility on Wall Street means contrarian stock picks can be a game-changer for savvy investors. A contrarian investing strategy involves buying overlooked assets with the expectation that they will eventually increase in value.
investorplace.comWhat's in Store for These 3 MedTech Stocks in Q2 Earnings?
1 monthMedTech companies' quarterly results are likely to be strong on a sequential basis. Let's see how BAX, HSIC and IDXX are placed ahead of their earnings releases.
zacks.comCountdown to Baxter (BAX) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
2 monthsGet a deeper insight into the potential performance of Baxter (BAX) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
zacks.comBaxter's (BAX) Helion Surgical System Debuts in Thailand
2 monthsBaxter (BAX) launches the Helion Integrated Surgical System in Thailand, aiming to streamline operating room efficiency and enhance surgical team connectivity with cutting-edge technology.
zacks.comBaxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
2 monthsDEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2024 financial results on Tuesday, August 6, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I898552708 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.c.
businesswire.comBaxter Declares Quarterly Dividend
2 monthsDEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on Oct. 1, 2024, to stockholders of record as of Aug. 30, 2024. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of diag.
businesswire.com